メインコンテンツにスキップ
1493件の検索結果

Certara Reports First Quarter 2024 Financial Result

Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024– Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2024. First Quarter Highlights: “I am pleased with our first quarter financial results, steered by solid execution across both software and services,” said William … Continued

https://www.certara.com/pressrelease/certara-reports-first-quarter-2024-financial-result/

A Best Practice Guide to CDISC SDTM Mapping

CDISC SDTM mapping made simple Is a drug working? Are there side effects? Is it safe to continue with a trial?   These questions can be answered by clear, comprehensive data analytics. But to get this information, you must first produce quality CDISC SDTM datasets. Mapping your clinical trial data to CDISC’s SDTM format is no … Continued

https://www.certara.com/fact-sheet/a-best-practice-guide-to-cdisc-sdtm-mapping/

Guide Download – A Best Practice Guide to CDISC SDTM Mapping

How about a free demo of Pinnacle 21 Clinical Data Management & Automation Suite? Complete the form to book your no-obligation demo of Pinnacle 21… and see how you can increase the speed and quality of your clinical trial submission data! Trusted by leading drug developers

https://www.certara.com/thank-you-guide-download-a-best-practice-guide-to-cdisc-sdtm-mapping/

How Chinese CRO, Zhejiang Longcharm Biomedical Technology Uses Pinnacle 21 Enterprise to Optimize Sponsors’ Non-clinical and Clinical Regulatory Affairs

Voice of the Customer Founded in 2016, Zhejiang Longcharm Biomedicine Technology Co., Ltd. provides one-stop R&D outsourcing services for the Chinese pharmaceutical industry. They can support BA/BE/PK clinical testing and data analysis services that comply with Chinese and American regulatory requirements for both novel and generic drug development programs. In 2023 July, Zhejiang Longcharm Bio-medical … Continued

https://www.certara.com/case-study/chinese-cro-uses-pinnacle-21-to-optimize-sponsors-clinical-regulatory-affairs/

EU CTIS: Europe’s New Clinical Trial Information System

EudraCT has been Europe’s clinical trial database for almost twenty years. But, now it’s the time to say goodbye to EudraCT and hello to the new Clinical Trial Information System (CTIS). CTIS will be the single entry point for submitting, assessing, authorizing, supervising, and reporting clinical trials in all EU Member States (Figure 1). It … Continued

https://www.certara.com/blog/ctis-europe-new-clinical-trial-information-system/

AI Enabling Biosimulation: Innovating the Path of Drug Research and Development

会場:Suzhou Adock Innovation Center (1F Multi-function Lecture Hall, Adock Innovation Center, No. 328 Xinghu Street, Suzhou Industrial Park, Suzhou, China) Overview: With the rapid development of technology, AI technology has penetrated all aspects of our lives. In the field of drug research and development, the combination of AI and biosimulation has brought revolutionary changes … Continued

https://www.certara.com/live-events/ai-enabling-biosimulation-innovating-the-path-of-drug-research-and-development/

APSTJ 2024

https://www.certara.com/conference/apstj-2024/

Why are Clinical Data Standards Essential for EDC and Non-EDC Data?

When you think of clinical data standardization, you might think of forms and datasets, or of CDISC’s CDASH, SDTM and ADaM models. And while these are an excellent and necessary starting point for standardization, it’s important to understand the many other ways you can use standardization to improve the efficiency of your clinical trials.    Clinical … Continued

https://www.certara.com/blog/why-are-clinical-data-standards-essential-for-edc-and-non-edc-data/

ISSX Workshop on Quantitative LC-MS/MS Proteomics

会場:Certara UK OfficesLevel 2-Acero1 Concourse WaySheffieldUnited Kingdom Online registration is available until: 6/29/2024 The workshop is neither trying to provide a 101 course on LCMS proteomics nor attempts to focus on what is new in LC-MS proteomics techniques. Attendees need to have some background but not necessarily leading experts in the field.

https://www.certara.com/live-events/issx-workshop-on-quantitative-lc-ms-ms-proteomics/
1 of 150
Powered by Translations.com GlobalLink OneLink Software